zalcitabine has been researched along with Granulocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brendel, M; Cinatl, J; Doerr, HW; Gussetis, ES; Kornhuber, B; Mainke, M; Nemeth, U | 1 |
1 other study(ies) available for zalcitabine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
2',3'-Dideoxycytidine preferentially inhibits in vitro growth of granulocyte-macrophage colony-forming cells from patients with chronic myeloid leukemia.
Topics: Bone Marrow; Deoxyadenosines; Deoxyuridine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Stem Cells; Zalcitabine | 1991 |